These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 5456660)

  • 41. [Technical disturbances, complications and causes of death in hemodialysed patients with chronic renal insufficiency during 1962-1966].
    Precht K; Hagemann I; Buchali K; Buder HW; Natusch R; Schröter R; Strangfeld D
    Z Urol Nephrol; 1968 Apr; 61(4):217-23. PubMed ID: 5652244
    [No Abstract]   [Full Text] [Related]  

  • 42. [GH, insulin and glucide intolerance in chronic uremia. Changes during hemodialysis treatment and after renal transplantation].
    Orsoni G; Capelli M; Scolari MP; Vangelista A; Bonomini V
    Minerva Nefrol; 1980; 27(4):655-8. PubMed ID: 7019773
    [No Abstract]   [Full Text] [Related]  

  • 43. [The excretion of ascorbic acid and its metabolites in uremia and hemodialysis].
    Bakaev VV; Efremov AV
    Patol Fiziol Eksp Ter; 2000; (2):22-4. PubMed ID: 10846906
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Prophylactic and conservative treatment of arteriovenous shunts in chronic kidney disease patients treated with periodic hemodialysis].
    Ancona G
    Chir Patol Sper; 1966; 14(7):246-65. PubMed ID: 5990179
    [No Abstract]   [Full Text] [Related]  

  • 45. Muscle protein metabolism during hemodialysis.
    Bohé J; Rennie MJ
    J Ren Nutr; 2006 Jan; 16(1):3-16. PubMed ID: 16414436
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diet therapy in uremia.
    Burton BT
    J Am Diet Assoc; 1969 Jun; 54(6):475-80. PubMed ID: 5798105
    [No Abstract]   [Full Text] [Related]  

  • 47. [Chronic hemodialysis with the aid of venipuncture and artificially created arteriovenous fistula].
    Franz HE; Roehl L; Vollmar J; Stein W
    Verh Dtsch Ges Inn Med; 1967; 73():997-9. PubMed ID: 5591870
    [No Abstract]   [Full Text] [Related]  

  • 48. [A new pathogenetic interpretation of the changes of acid-base equilibrium during hemodialysis].
    Graziani G; Ponticelli C; Redaelli B; Pincella G; Di Filippo G
    Minerva Nefrol; 1970; 17(6):198-203. PubMed ID: 5516055
    [No Abstract]   [Full Text] [Related]  

  • 49. [Results of the first 5 years of the "chronic hemodialysis program" at Szeged].
    Gál G; Mustárdy I; Hézsai K; Kárpáti F; Petri G
    Orv Hetil; 1974 Aug; 115(33):1927-31. PubMed ID: 4846485
    [No Abstract]   [Full Text] [Related]  

  • 50. Residual function in chronic renal insufficiency under regular dialysis treatment.
    Erben J
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1980; 23(1):1-112. PubMed ID: 6966816
    [No Abstract]   [Full Text] [Related]  

  • 51. [Granulocytopoiesis in chronic uremia patients undergoing periodic hemodialysis (granulocyte kinetics studied with Se75-seleniomethionine)].
    Lusvarghi E; Mauri C; Senter M; Curci G; Sacchi S; Davoli D; Furci M; Grosoli M
    Minerva Nefrol; 1982; 29(4):205-10. PubMed ID: 7155440
    [No Abstract]   [Full Text] [Related]  

  • 52. [Care of chronic kidney patients. Possibilities and limits of prevention, treatment and rehabilitation in the clinical stage of chronic kidney insufficiency].
    Buchborn E
    Internist (Berl); 1983 Sep; 24(9):487-93. PubMed ID: 6354966
    [No Abstract]   [Full Text] [Related]  

  • 53. Ethical issues in Czech renal failure.
    Honzak R
    Bull Med Ethics; 1992 May; (78):21-2. PubMed ID: 15997528
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cardiovascular disease in haemodialysis and peritoneal dialysis: arguments pro haemodialysis.
    Segall L; Covic A
    Nephrol Dial Transplant; 2007 Jan; 22(1):59-63. PubMed ID: 17099221
    [No Abstract]   [Full Text] [Related]  

  • 55. Pharmacokinetics of the cephalosporins in healthy volunteers and uremic patients.
    Kirby WM; De Maine JB; Serrill WS
    Postgrad Med J; 1971 Feb; 47():Suppl:41-6. PubMed ID: 5556189
    [No Abstract]   [Full Text] [Related]  

  • 56. [Evaluation of erythropoiesis in uremic patients during conservative therapy and in the course of prolonged hemodialysis (using Fe59)].
    Lamperi S; Sitia L; Bandiani G; Muttini P
    Minerva Nefrol; 1970; 17(3):94-9. PubMed ID: 5515034
    [No Abstract]   [Full Text] [Related]  

  • 57. [Dynamics of insulin secretion in terminal kidney failure and during chronic, intermittent dialysis treatment].
    Hübner W; Freiberg J; Fuss-Jahn B
    Verh Dtsch Ges Inn Med; 1974; 80():697-701. PubMed ID: 4217996
    [No Abstract]   [Full Text] [Related]  

  • 58. [Treatment with high-dose intravenous iron increases mortality and hospitalization in hemodialysis. The basic idea is more important than the style].
    Fernández-Gallego J
    Nefrologia; 2005; 25(3):340. PubMed ID: 16053019
    [No Abstract]   [Full Text] [Related]  

  • 59. Are biocompatible membranes superior for hemodialysis therapy?
    van Ypersele de Strihou C
    Kidney Int Suppl; 1997 Nov; 62():S101-4. PubMed ID: 9350694
    [No Abstract]   [Full Text] [Related]  

  • 60. Uremia and adequate dialysis treatment.
    Acchiardo SR
    Semin Nephrol; 1994 May; 14(3):274-81. PubMed ID: 8036362
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.